Side Effects of Drugs Annual
Elsevier Science Ltd (Verlag)
978-0-444-51571-1 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
Volume 28 in the series of Side Effects of Drugs Annuals (http://www.elsevier.com/locate/series/seda) continues to serve its primary goal: to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has reviewed new data and trends by selecting from the year's writing all that is truly new and informative, by critically interpreting it, and by pointing to whatever is unproven or misleading. The use of the book is enhanced by separate indexes, allowing the reader to access the text via drug name, adverse effect, or drug interaction.
The current annual includes an essay by the editor, Dr Jeffrey Aronson, entitled 'Classifying Drug Adverse Reactions in the 21st Century.' In it he describes how the modern approach to classifying adverse drug reactions takes into account the dose that causes the reaction, the time-course of the reaction, and the susceptibility factors that increase the individual patient's risk, and shows how this analysis can facilitate regulatory decision making.
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK’s National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.
Classifying adverse drug reactions in the 21st century
J.K. Aronson
1. Central nervous system stimulants and drugs that suppress appetite
R.P. Sequeira
2. Antidepressant drugs
P.J. Cowen
3. Lithium
D.L. Dunner
4. Drugs of abuse
J.K. Patel, Timothy E Ralston, and E.J. wong
5. Hypnotics and sedatives
S. Curran and S. Musa
6. Antipsychotic drugs
A. Carvajal,L.H. Martín Arias and Natalia Jimeno
7. Antiepileptic drugs
A. Gil-Nagel
8. Opioid analgesics and narcotic antagonists
A.H. Ghodse and A.M. Baldacchino
9. Anti-inflammatory and antipyretic analgesics and drugs used in gout
A. Del Favero
10. General anesthetics and therapeutic gases
Y. Young
11. Local anesthetics
S.A. Schug, P. Flisberg, S.A. Jackson, D.J. O’Connnor
12. Neuromuscular blocking agents and skeletal muscle relaxants
O. Zuzan and M. Leuwer
13. Drugs that affect autonomic functions or the extrapyramidal system
M. Schachter
14. Dermatological drugs and topical agents
S.R. Knowles, G. Wong, N.H. Shear
15. Antihistamines (H1 receptor antagonists)
G.M. Walsh
16. Drugs acting on the respiratory tract
M. Joerger, K. Hartmann, and M. Kuhn
17. Positive inotropic drugs and drugs used in dysrhythmias
J.K. Aronson
18. Beta-adrenoceptor antagonists and antianginal drugs
A.P. Maggioni, M.G. Franzosi, and R. Latini
19. Drugs acting on the cerebral and peripheral circulations
R. Verhaeghe
20. Antihypertensive drugs
P. Joubert
21. Diuretics
D.A. Sica
22. Metals
G.B. van der Voet and F.A. de Wolff
23. Metal antagonists
R.H.B. Meyboom
24. Antiseptic drugs and disinfectants
P. Magee
25. Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines
T. Midtvedt
26. Miscellaneous antibacterial drugs
A. Imhof
27. Antifungal drugs
A.H. Groll, H. Kolve, and T.J. Walsh
28. Antiprotozoal drugs
J. Buser, K. Fattinger
29. Antiviral drugs
P.L. Vernazza, P. Schmid
30. Drugs used in tuberculosis and leprosy
S. Swaminathan
31. Antihelminthic drugs
P.J.J. van Genderen
32. Vaccines
S. Dittmann
33. Blood, blood components, plasma and plasma products
P.J.M. Vossebeld, P. Stangers and W.G. van Aken
34. Formulations used in nutrition
M.C. Allwood and G. Hardy
35. Drugs affecting blood coagulation, fibrinolysis, and hemostasis
D. Keeling and J.K. Aronson
36. Gastrointestinal drugs
S. Dar, H.N. Dalton
37. Drugs that act on the immune system: cytokines and monoclonal antibodies
T.Vial, J. Descotes, C. Ludwig, and M. Behrend
38. Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs
F. Braun and M. Behrend
39. Corticotrophins, corticosteroids, and prostaglandins
J. Costa and M. Farré
40. Sex hormones and related compounds, including hormonal contraceptives
M.N.G. Dukes
41. Thyroid hormones iodine, and antithyroid drugs. J.A. Franklyn
42. Insulin, glucagon, and hypoglycemic drugs
H.M.J. Krans
43. Miscellaneous hormones
R. Page
44. Drugs that affect lipid metabolism
I. Aursnes
45. Cytostatic drugs
Hans-Peter Lipp, Jörg Thomas Hartmann, and Andrew Stanley
46. Radiological contrast agents
S.K. Morcos
47. Drugs used in ocular treatment
B.C.P. Polak
48. Treatments used in complementary and alternative medicine
E. Ernst
49. Miscellaneous drugs and materials, medical devices and techniques
N.H. Choulis and J.K. Aronson
Erscheint lt. Verlag | 29.11.2005 |
---|---|
Reihe/Serie | Side Effects of Drugs Annual |
Verlagsort | Oxford |
Sprache | englisch |
Maße | 165 x 240 mm |
Gewicht | 1380 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
ISBN-10 | 0-444-51571-2 / 0444515712 |
ISBN-13 | 978-0-444-51571-1 / 9780444515711 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich